Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sagimet Biosciences (SGMT) Cash from Investing Activities (2022 - 2026)

Sagimet Biosciences' Cash from Investing Activities history spans 5 years, with the latest figure at $10.2 million for Q1 2026.

  • Quarterly Cash from Investing Activities rose 199.33% to $10.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $11.4 million through Mar 2026, up 118.54% year-over-year, with the annual reading at $4.6 million for FY2025, 107.39% up from the prior year.
  • Cash from Investing Activities came in at $10.2 million for Q1 2026, down from $14.4 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $19.4 million in Q1 2023 to a low of -$75.2 million in Q2 2024.
  • The 5-year median for Cash from Investing Activities is $3.7 million (2022), against an average of -$1.8 million.
  • Year-over-year, Cash from Investing Activities tumbled 687.16% in 2024 and then skyrocketed 199.33% in 2026.
  • Sagimet Biosciences' Cash from Investing Activities stood at $5.4 million in 2022, then tumbled by 460.93% to -$19.6 million in 2023, then surged by 150.2% to $9.8 million in 2024, then skyrocketed by 45.77% to $14.4 million in 2025, then decreased by 28.85% to $10.2 million in 2026.
  • Per Business Quant, the three most recent readings for SGMT's Cash from Investing Activities are $10.2 million (Q1 2026), $14.4 million (Q4 2025), and $75000.0 (Q3 2025).